Commission Implementing Regulation (EU) 2023/948 of 12 May 2023 authorising the placing on the market of 6′-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act included in a Joint Committee Decision (JCD); entry into force of the Decision is pending Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XII Foodstuffs
Legal documents
Commission Implementing Regulation (EU) 2023/948 of 12 May 2023 authorising the placing on the market of 6′-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470
Durchführungsverordnung (EU) 2023/948 der Kommission vom 12. Mai 2023 zur Genehmigung des Inverkehrbringens von 6′-Sialyllactose-Natriumsalz, erzeugt mit abgeleiteten Stämmen von Escherichia coli BL21(DE3), als neuartiges Lebensmittel und zur Änderung der Durchführungsverordnung (EU) 2017/2470
History
23.09.2023
Adopted JCD confirmed entry into force date
23.09.2023
Compliance date in the EEA
22.09.2023
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
12.07.2023
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
12.05.2023
Adoption date in the EU
04.06.2023
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.